Endo Par Pharmaceuticals
Legal Battle Unfolds as Endo’s Par Pharmaceuticals Defends Exclusive Rights to Chantix Amid Generic Rivalry
SG Tylor
Following the recall of Pfizer’s smoking cessation drug Chantix in 2021, Endo’s subsidiary Par Pharmaceuticals has stood as the sole ...
